Jubilant Life Sciences is currently trading at Rs. 706.35, up by 1.90 points or 0.27% from its previous closing of Rs. 704.45 on the BSE.
The scrip opened at Rs. 715.00 and has touched a high and low of Rs. 718.80 and Rs. 692.20 respectively. So far 69338 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 765.00 on 07-Feb-2017 and a 52 week low of Rs. 278.80 on 12-Feb-2016.
Last one week high and low of the scrip stood at Rs. 765.00 and Rs. 671.60 respectively. The current market cap of the company is Rs. 11320.91 crore.
The promoters holding in the company stood at 54.02%, while institutions and non-institutions held 26.50% and 19.47% respectively.
Jubilant Life Sciences has received an approval for acquisition of 18,66,20,000 12% Optionally Convertible Non-cumulative Redeemable Preference Shares of Rs 10 each of Jubilant Biosys at par aggregating to Rs 186.62 crore, subject to applicable laws. The board of directors at its meeting held on February 07, 2017, has approved for the same.
Jubilant Life Sciences is engaged in manufacturing and supply of active pharmaceutical ingredient (APIs), solid dosage formulations, radio pharmaceuticals, allergy therapy products and life science ingredients. It also provides services in contract manufacturing of sterile injectables and ointments, creams and liquids and drug discovery and development.